New patient survey reveals: For people with atrial fibrillation, revers
89% of surveyed patients with atrial fibrillation (AF) are aware of potentia...
2018-07-02
文传商讯
Pradaxa: First NOAC to be assessed in prospective study in patients wit
RE-SPECT CVT® is a Phase III study of dabigatran etexilate (Pradaxa®...
2016-05-13
文传商讯
Boehringer Ingelheim launches RE-COVERY DVT/PE TM: global observational
First patient enrolled in RE-COVERY DVT/PE™Involving 14,000 patients w...
2016-03-24
文传商讯
